The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India 1 , 2 , 3 , 4 – 5 .
Since then, it has become dominant in some regions of India and in the UK, and has spread to …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …

Severe cases of COVID‐19 are associated with extensive lung damage and the presence of
infected multinucleated syncytial pneumocytes. The viral and cellular mechanisms …

It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …

Severe COVID‐19 is characterized by lung abnormalities, including the presence of syncytial
pneumocytes. Syncytia form when SARS‐CoV‐2 spike protein expressed on the surface of …

Syncytia are formed when individual cells fuse. SARS-CoV-2 induces syncytia when the viral
spike (S) protein on the surface of an infected cell interacts with receptors on neighboring …

The SARS-CoV-2 B.1.617 lineage emerged in October 2020 in India 1 – 6 . It has since then
become dominant in some indian regions and further spread to many countries. The …

It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their antibody response profile. Here, we performed …

Four endemic seasonal human coronaviruses causing common colds circulate worldwide:
HKU1, 229E, NL63 and OC43 (ref. ). After binding to cellular receptors, coronavirus spike …

This month’s cover highlights the article Architecture of the active post‐translational Sec
translocon by Tsai‐Hsuan Weng, Jingdong Cheng, Roland Beckmann and colleagues. Newly …